Who is sponsoring NCT05954572?

NCT05954572 is sponsored by Hasan Aksoy.

What drugs are being tested in NCT05954572?

Interventions in NCT05954572: standardized skin surface biopsy (SSSB).

What condition does NCT05954572 study?

NCT05954572 studies Demodicidosis.

Is NCT05954572 still recruiting?

NCT05954572 is currently status unknown. Last updated 20 July 2023.

Last reviewed 2023-07-20 · How we verify

NCT05954572

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Association Between Biologic Therapy and Demodex Density in Psoriasis Patients: A Comparative Study

Status unknown Last updated 20 July 2023

What this trial tests

trial testing standardized skin surface biopsy (SSSB) in Demodicidosis in 34 participants. Status unknown.

Timeline

14 July 2023

Primary endpoint
14 August 2023

14 August 2023

Quick facts

Lead sponsor	Hasan Aksoy
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	34
Start date	14 July 2023
Primary completion	14 August 2023
Estimated completion	14 August 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

standardized skin surface biopsy (SSSB)

Conditions studied

Demodicidosis — all drugs for Demodicidosis →

Sponsor

Hasan Aksoy

Who can join

Adults 18 to 70, any sex, with Demodicidosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to investigate whether the density of Demodex mites is higher in psoriasis patients treated with biologic agents compared to treatment-naive or topically treated patients. The main question\[s\]it aims to answer are: * Are Demodex mites higher in psoriasis patients treated with biologic agents? * In which localization and with what intensity was demodicosis most common? Participants will be assessed using standardized skin surface biopsy technique in four localization on their face . Researchers will compare demodex intensity per cm² to see if the biologic treatments effects demodex intensity on psoriasis patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05954572 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hasan Aksoy
Last refreshed: 20 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05954572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing